Gagandeep Singh Bedi has resigned as managing director, according to a statement released by AstraZeneca Pharma India on Wednesday.
The pharmaceutical company announced that Sanjeev Panchal has been appointed as managing director for a three-year term beginning January 1, 2023.
According to the statement, Panchal began working for AstraZeneca Pharma in February 2003 as a brand associate and advanced through a number of positions in Singapore and the United Kingdom (UK), India, Indonesia, and the Asia Pacific area.For feedback and suggestions, write to us at email@example.com
Invest wise with Expert advice
The US Federal committee's meeting will conclude on March 16, 2022.
No Record Found